Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05536726
What this trial is testing

Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 458
Not applicableStudy completedNCT04433442
What this trial is testing

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie 2,324
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Not applicableActive Not RecruitingNCT07244744
What this trial is testing

Tilrdakizumab Almirall

Who this might be right for
Psoriasis
University Hospital Schleswig-Holstein 3
Post-approval studies (Phase 4)Study completedNCT00655564
What this trial is testing

Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis

Who this might be right for
Psoriasis
Wake Forest University 15
Not applicableStudy completedNCT05959070
What this trial is testing

An Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)

Who this might be right for
Psoriasis
AbbVie 154
Testing effectiveness (Phase 2)Study completedNCT01901705
What this trial is testing

Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis

Who this might be right for
Psoriasis
China Medical University Hospital 24
Post-approval studies (Phase 4)Study completedNCT06333860
What this trial is testing

Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Who this might be right for
Moderate Plaque Psoriasis
AbbVie 393
Post-approval studies (Phase 4)Study completedNCT04229836
What this trial is testing

Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)

Who this might be right for
Plaque Psoriasis
Almirall, S.A. 178
Large-scale testing (Phase 3)Study completedNCT05108766
What this trial is testing

A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis

Who this might be right for
Plaque Psoriasis
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT07712705
What this trial is testing

HPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.

Who this might be right for
Psoriasis
Newsoara Biopharma Co., Ltd. 515
Testing effectiveness (Phase 2)Study completedNCT05858047
What this trial is testing

An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque Psoriasis

Who this might be right for
Effects, Drug Side
CSPC Ouyi Pharmaceutical Co., Ltd. 93
Large-scale testing (Phase 3)Study completedNCT02748863
What this trial is testing

Study of Secukinumab With 2 mL Pre-filled Syringes

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 214
Large-scale testing (Phase 3)Study completedNCT01186744
What this trial is testing

Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 666
Testing effectiveness (Phase 2)Study completedNCT02852967
What this trial is testing

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Kadmon Corporation, LLC 110
Testing effectiveness (Phase 2)Study completedNCT02762994
What this trial is testing

International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Biocad 120
Large-scale testing (Phase 3)Study completedNCT00096603
What this trial is testing

Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Who this might be right for
Psoriasis
Genentech, Inc. 450
Not applicableStudy completedNCT05863273
What this trial is testing

Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）

Who this might be right for
Psoriasis
First Hospital of China Medical University 360
Testing effectiveness (Phase 2)Study completedNCT02905006
What this trial is testing

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation